Breaking News Instant updates and real-time market news.

OPTN

Optinose

$21.92

0.26 (1.20%)

16:29
08/07/18
08/07
16:29
08/07/18
16:29

Optinose initiated with an Overweight at Cantor Fitzgerald

Cantor Fitzgerald analyst William Tanner started Optinose with an Overweight rating and $30 price target.

OPTN Optinose
$21.92

0.26 (1.20%)

07/18/18
BMOC
07/18/18
NO CHANGE
Target $30
BMOC
Outperform
Optinose's Xhance uptake is promising thus far, says BMO Capital
BMO Capital analyst Gary Nachman kept his Outperform rating and $30 price target on Optinose, saying his meetings with the company management revealed that they are pleased with the up take of Xhance thus far. The analyst states that the company is now "focused on achieving a solid conversion with the help of the new Xtended Patient Support program", having discussed the expansion strategies such as promotional activities, salesforce, and a broader indication. Nachman maintains his view of a "significant opportunity" for the Xhance treatment.
07/18/18
PIPR
07/18/18
NO CHANGE
Target $34
PIPR
Overweight
Optinose price target raised to $34 from $29 at Piper Jaffray
Piper Jaffray analyst David Amsellem raised his price target for Optinose to $34 after hosting investor meetings with management. The latest data points regarding the growth in the total number of units dispensed via Optinose's Xhance Xperience program are encouraging, Amsellem tells investors in a research note. The analyst remains confident that the company will start to see significant growth in retail volumes in the coming months as patients transition from their samples to being retail customers. He reiterates an Overweight rating on Optinose shares.
06/14/18
BMOC
06/14/18
NO CHANGE
Target $30
BMOC
Outperform
Optinose increasingly confident on Xhance launch, says BMO Capital
After meeting with Optinose, BMO Capital analyst Gary Nachman says management's optimism and confidence regarding the outlook for Xhance continues to increase. Initial metrics have exceeded internal expectations, and Optinose is demonstrating an "ability to quickly evolve its thinking as necessary to maximize the value of the launch curve," Nachman tells investors in a research note. The analyst reiterates Optinose as a top small-cap pick with an Outperform rating and $30 price target.
04/06/18
JEFF
04/06/18
NO CHANGE
Target $31
JEFF
Buy
Optinose launch of Xhance could far exceed expectations, says Jefferies
After surveying 50 high prescribing physicians, Jefferies analyst David Steinberg says Optinose's launch of Xhance could far exceed expectations. Physicians report 57% of their patients will receive prescriptions annually at peak, Steinberg tells investors in a research note. Using the most conservative response regarding patient use per year, implied peak sales could reach $1.1B, well above the $700M consensus, the analyst contends. He believes that while payer pushback is inevitable, the survey suggests Xhance "could be one of the top sector launches in some time." The anlayst keeps a Buy rating on Optinose shares with a $31 price target.

TODAY'S FREE FLY STORIES

TSRO

Tesaro

$37.18

2.22 (6.35%)

13:25
11/19/18
11/19
13:25
11/19/18
13:25
Options
TESARO call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

TRI

Thomson Reuters

$48.53

-0.47 (-0.96%)

13:25
11/19/18
11/19
13:25
11/19/18
13:25
Conference/Events
Thomson Reuters to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 04

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
11/19/18
11/19
13:17
11/19/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
11/19/18
11/19
13:16
11/19/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADI

Analog Devices

$86.70

-2.79 (-3.12%)

13:15
11/19/18
11/19
13:15
11/19/18
13:15
Options
Analog Devices put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 26

    Nov

13:10
11/19/18
11/19
13:10
11/19/18
13:10
General news
Euro$ interest rate futures are feeling their oats »

Euro$ interest rate…

BSX

Boston Scientific

$35.50

-1.72 (-4.62%)

13:05
11/19/18
11/19
13:05
11/19/18
13:05
Recommendations
Boston Scientific analyst commentary  »

Boston Scientific price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

AA

Alcoa

$33.20

-2.73 (-7.60%)

13:05
11/19/18
11/19
13:05
11/19/18
13:05
Options
Alcoa call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$131.85

-7.7 (-5.52%)

13:04
11/19/18
11/19
13:04
11/19/18
13:04
Periodicals
Instagram is removing inauthentic followers, TechCrunch reports »

Facebook's Instagram…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

LRLCY

L'Oreal

$0.00

(0.00%)

13:03
11/19/18
11/19
13:03
11/19/18
13:03
Hot Stocks
L'Oreal appoints Christophe Babule to succeed Christian Mulliez as CFO »

L'Oreal announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$37.48

2.52 (7.21%)

13:03
11/19/18
11/19
13:03
11/19/18
13:03
Hot Stocks
Tesaro rallies after canceling appearance at Evercore conference »

Shares of Tesaro are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

SCGLY

Societe Generale

$0.00

(0.00%)

12:56
11/19/18
11/19
12:56
11/19/18
12:56
Hot Stocks
Societe Generale says $1.3B settlement covered by provision for disputes »

Societe Generale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BILI

Bilibili

$13.47

-1.01 (-6.98%)

12:55
11/19/18
11/19
12:55
11/19/18
12:55
Options
Bilibili put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

12:55
11/19/18
11/19
12:55
11/19/18
12:55
General news
Treasury Action: yields rolled over from highs »

Treasury Action: yields…

TWTR

Twitter

$32.25

-1.45 (-4.30%)

12:49
11/19/18
11/19
12:49
11/19/18
12:49
Periodicals
Twitter de-emphasize follower counts in iOS redesign, Verge says »

The follower count on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

PBR

Petrobras

$14.60

-0.27 (-1.82%)

12:46
11/19/18
11/19
12:46
11/19/18
12:46
Periodicals
Petrobras' Branco says BR Distribuidora not a natural fit, Reuters says »

Incoming Petrobras CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$114.20

0.35 (0.31%)

12:45
11/19/18
11/19
12:45
11/19/18
12:45
Options
Eli Lilly call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

INGN

Inogen

$137.12

-4.73 (-3.33%)

, RMD

ResMed

$102.53

-1.58 (-1.52%)

12:43
11/19/18
11/19
12:43
11/19/18
12:43
Recommendations
Inogen, ResMed analyst commentary  »

Mobi looks…

INGN

Inogen

$137.12

-4.73 (-3.33%)

RMD

ResMed

$102.53

-1.58 (-1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 04

    Dec

MDT

Medtronic

$90.66

-3.02 (-3.22%)

12:35
11/19/18
11/19
12:35
11/19/18
12:35
Options
Medtronic put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Dec

SCGLY

Societe Generale

$0.00

(0.00%)

12:34
11/19/18
11/19
12:34
11/19/18
12:34
Hot Stocks
Societe Generale agrees to pay $1.34B for violations of U.S. sanctions »

The Federal Reserve Board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$269.10

-4.65 (-1.70%)

12:30
11/19/18
11/19
12:30
11/19/18
12:30
Periodicals
China's WTO envoy says China to propose WTO changes, Reuters says »

Zhang Xiangchen,…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$269.10

-4.65 (-1.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$30.41

0.11 (0.36%)

12:26
11/19/18
11/19
12:26
11/19/18
12:26
Periodicals
White House still seeking to take Jim Acosta's press pass away, WSJ says »

The White House is still…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

PEP

PepsiCo

$118.30

-0.09 (-0.08%)

12:25
11/19/18
11/19
12:25
11/19/18
12:25
Options
PepsiCo call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 15

    Feb

AAL

American Airlines

$35.36

-1.38 (-3.76%)

12:22
11/19/18
11/19
12:22
11/19/18
12:22
Hot Stocks
APA seeks to open contract negotiations with American Airlines »

The Allied Pilots…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/19/18
11/19
12:17
11/19/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.